sulfasalazin penicillin sulfasalazin och alkohol sulfasalazin forum
Building Healthy Partnership
Date: 04/05/2017

Though India has scored several successes such as eradication of polio and reduction in the rates of infant and maternal mortality, there’s a long road ahead

zyprexa 60 mg zyprexa the oa
atomoxetin fass atomoxetin lilly atomoxetin hydrochlorid
Hilleman Laboratories signs MoU with NICED, ICMR to develop Shigella Vaccine
Date: 29/03/2017

March 29th, 2017, New Delhi: Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, today, signed a Memorandum of Understanding (MoU) with National Institute of Cholera and Enteric Diseases (NICED), an ICMR organization for further development and commercialization of the Shigella vaccines and other enteric vaccines for diarrheal diseases. This agreement was signed as an effort of Hilleman’s mission to make affordable vaccines for the developing world population.

sulfasalazin penicillin sulfasalazin en 500 mg sulfasalazin forum
Hilleman Laboratories awarded global patents for Oral Cholera Vaccine
Date: 10/01/2017

New Delhi, 10 January, 2017: Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, has announced that it has been awarded a set of global patents for its Oral Cholera Vaccine (OCV).

Nitya Sharma at Hilleman Labs and Amity University awarded the prestigious Prime Minister’s Fellowship
Date: 22/12/2016

Hilleman Labs partners with Amity University for the Prime Minister’s Fellowship Scheme for Doctoral Research. Nitya Sharma, a PhD (Immunology) scholar at Amity University is working on the development of immunodiagnostic assays for meningococcal antigens at Hilleman Labs

Sustained funding is difficult to get in India
Date: 11/10/2016

Corporate India hasn’t developed a high appetite for risk, in terms of accepting new technology. India is still evolving. Most companies like to go for tried-and-tested methods, rather than innovation

Hilleman Lab scouts for partners to launch rotavirus vaccine in India
Date: 28/09/2016

New Delhi: Hilleman Laboratories, an initiative between pharmaceutical giant Merck & Co (MSD Pharmaceuticals in India) and UK-based charitable organization Wellcome Trust, is in talks to partner domestic and global vaccine companies to manufacture and market its thermostable, or heat-resistant, rotavirus vaccine in India.

Hilleman Labs workshop on Nutrition and Immunity for Infant and Child Health
Date: 21/09/2016

New Delhi:Hilleman Laboratories, dedicated for improvement of child health by developing affordable vaccine for the developing world also understands and recognizes the importance of interplaying role of nutrition and immunity as the key factors along with vaccination in reducing childhood mortality and improving child health and development.

Hilleman Laboratories scientist Dr. Ankur Mutreja awarded prestigious - “DBT Cambridge Lectureship”
Date: 23/06/2016

New Delhi, 23rd June 2016: Recognising an exemplary achievement by one of its scientists, Hilleman Laboratories, a first-of- its-kind joint-venture partnership between MSD and the Wellcome Trust, proudly announces Dr. Ankur Mutreja’s appointment at the University of Cambridge under the prestigious “DBT Cambridge Lectureship” programme. I

motilium 1mg/ml motilium arabe
jasmine disney jasmine tridevil jasmine pilchard-gosnell
actostor vih actos spc actos
sildenafil ratiopharm open sildenafil preis
viagra online kaufen viagra generika viagra ersatz
Hilleman Laboratories advances two vaccines into clinical stage
Date: 27/04/2016

New Delhi, 27th April 2016: Advancing closer to its vision of bridging the vaccination gap in developing nations, Hilleman Laboratories, a first-of-its-kind joint-venture between Merck Sharp & Dohme (MSD) and the Wellcome Trust, today announced the initiation of Phase I/II clinical trial of its innovative vaccine, an oral, lyophilized, heat-stable Rotavirus vaccine, against Rotavirus disease. After successful completion of the preclinical stage and obtaining regulatory clearance, Hilleman Laboratories has initiated a clinical study to establish proof-of-concept for its heat stable Rotavirus vaccine candidate.

motilium vet motilium vet
lithium nirvana lithium nirvana
jasmine disney jasmine tridevil jasmine pilchard-gosnell
sildenafil ratiopharm link sildenafil preis
amoxicillin allergy amoxicillin dosage
Hilleman Laboratories Announces Key Senior Leadership Appointment
Date: 08/04/2016

New Delhi, 8th April, 2016: Hilleman Laboratories, a first-of-its-kind joint-venture partnership between Merck & Co. and Wellcome Trust, today announced the appointment of Dr. Sudeep Singh Gadok as Senior Vice President - Enterprise Development. In this role, Dr. Gadok is entrusted with a dynamic portfolio which includes fostering strategic partnerships, resource development, fundraising and communications. Dr. Gadok joins Hilleman Laboratories from Save the Children, where he was the Director of Programs for India, leading all the technical, thematic and programme operations & management teams.